November 14, 2024 Webinar: Advanced in vitro modelling of neuromuscular diseases and therapeutics Join us on November 14 at 12 p.m. eastern for a webinar that will explore innovative, multidisciplinary....
October 29, 2024 Webinar: New Findings on Inequities in Rare Diseases: How They Impact Research and Clinical Trials Processes Join us Tuesday, October 29, at noon Eastern for an important webinar, New Findings on Inequities in Rare Diseases...
October 16, 2024 ADHD Awareness Month: Addressing Disparities in Diagnosis and Treatment October is ADHD Awareness Month, dedicated to raising awareness about Attention Deficit Hyperactivity Disorder (ADHD) and
October 16, 2024 Sanford Health Rare Disease Data Registry and C-Path’s RDCA-DAP Enter into a Master Data Contribution Agreement to Aggregate Rare Disease Data Critical Path Institute (C-Path) is pleased to announce the expansion of our partnership with the Coordination...
November 5, 2024 C-Path Scientific Directors Belmonte, Kosinski to Present at 20th IDS Congress Paul Belmonte, C-Path’s Scientific Director, T1D Consortium, and Luke Kosinski, Director, Quantitative Medicine, will present...
September 30, 2024 TNF-α inhibitors for type 1 diabetes: exploring the path to a pivotal clinical trial Type 1 diabetes (T1D) is an autoimmune disease characterized by the destruction...
October 8, 2024 Flexible approaches to eCOA administration in clinical trials: The site perspective Estelle Haenel, Celeste A. Elash, Katie Garner, Megan Turner, Scottie KernAbstract Electronic Clinical Outcome Assessment (eCOA) C
October 2, 2024 From Words to Action: Ensuring True Accessibility at Scientific Conferences I want to talk about access and inclusion at scientific conferences and putting actions to words or values. Conferences are...
October 1, 2024 The AMR Accelerator Calls to Action: European Capacity for Antibiotic R&D Requires Long-term Funding Note: You are reading this information because Critical Path Institute is a partner of both ERA4TB and Unite4TB.
September 30, 2024 C-Path to Lead Comprehensive Task Force Focused on Accelerating Drug Development for Limb-Girdle Muscular Dystrophies C-Path announced the formation of a new task for under its RDCA-DAP, dedicated to...